Results 191 to 200 of about 149,760 (296)

Living Microbial Drugs

Chemistry – A European Journal, EarlyView.
The introduction outlines the review scope. Microbial cell factories as living drugs cover host–gut microbiota, bacteria, yeast, and other microbial systems, with comparative host advantages. Engineering strategies include synthetic circuits, quorum sensing, and memory.
Cemile Elif Özçelik, Nazlıcan Tunç, Senem Şen, Urartu Özgür Şafak Şeker   +3 more
wiley   +1 more source

Strengthening genomic surveillance for neglected tropical diseases in the Americas. [PDF]

Lancet Reg Health Am
The Lancet Regional Health-Americas.
europepmc   +1 more source

From Metabolic Crisis to Molecular Classification: Multidisciplinary Management of Synchronous Endometrioid Ovarian and Endometrial Carcinomas With Massive Tumor Burden

Cancer Nexus, EarlyView.
Managing massive tumor burden in synchronous endometrioid carcinomas. The graphical abstract summarizes the clinical pathway from presentation with massive ascites, pleural effusion, and critical metabolic abnormalities to multidisciplinary stabilization, surgical management, integrated morphologic–molecular classification, and shared decision‐making ...
Anna Homeniuk, Leena Abdalla, Sharon Fitzgerald   +2 more
wiley   +1 more source

Realising genomic field epidemiology: Prospective genomic and epidemiological surveillance for routine public health practice

© 2024 Courtney Renee LanePathogen genomics has the potential to transform public health, with the ability to reveal knowledge about the spread, sources, and characteristics of infectious diseases, through detailed comparison of pathogens’ genetic code ...
Lane, Courtney Renee
core  

Expanded Genomic Surveillance and Seasonal Comparisons of Human Respiratory Syncytial Virus Infections in Minnesota, USA, 2023-2025. [PDF]

Influenza Other Respir Viruses
Evans D, Kunerth H, Mumm E, Plumb M, Bohnker-Voels L, Bistodeau S, Cunningham SA, Davis J, Martin K, Como-Sabetti K, Namugenyi S, Wang X, Lynfield R, Strain A, Vetter S.   +14 more
europepmc   +1 more source

A Survival Epidemiology Framework for Oral and Oropharyngeal Cancer

Cancer Nexus, EarlyView.
ABSTRACT Oral and oropharyngeal cancer remains a major global public health burden, but the literature addressing this disease is still organized predominantly around who develops it rather than around what determines life after diagnosis. That imbalance is consequential because diagnosis initiates a new scientific problem.
Raphael E. Cuomo
wiley   +1 more source

Monitoring viral evolution and epidemiological characteristics of SARS-CoV-2 during 2022-2023 using Integrated Genomic Surveillance. [PDF]

Commun Med (Lond)
Mache C, Kerber R, Schulze J, Lataretu M, Abunijela S, Seyam Y, Paraskevopoulou S, Oh DY, Arlt M, Radonić A, Sedaghatjoo S, Budt M, Lehfeld AS, Hartkopf F, Dürrwald R, Semmler T, Haas W, Fuchs S, Kröger S, Wolff T, Integrated Molecular Surveillance for SARS-CoV-2 (IMSSC2) Laboratory Network.   +20 more
europepmc   +1 more source

Potential for use of Al/machine learning for pharmacovigilance: Is there a role for regulators?

British Journal of Clinical Pharmacology, EarlyView.
Christina Gao, Ashley M. Hopkins, Andrew Rowland, Stephen Bacchi   +3 more
wiley   +1 more source

From Inflammatory Bowel Disease to Cancer: Gut Microbiota–Immune Microenvironment Crosstalk and Natural Product‐Based Therapeutic Opportunities

Cancer Nexus, EarlyView.
ABSTRACT Inflammatory bowel disease (IBD), primarily Crohn's disease and ulcerative colitis, is a chronic relapsing inflammatory disorder of the gastrointestinal tract and an important risk factor for IBD‐associated cancer. Increasing evidence suggests that gut microbiota dysbiosis, epithelial barrier dysfunction, and immune microenvironment remodeling
Xue Zhang, Chongchong Gao, Rui Jiang, Zijian Wu, Jian Bai   +4 more
wiley   +1 more source

Genomic Surveillance of Respiratory Syncytial Virus in Sydney Reveals Rebound in Postpandemic Viral Diversity. [PDF]

Open Forum Infect Dis
Herkes JMS, Foster CSP, Michie A, Bartlett AW, Rawlinson WD, Walker GJ.   +5 more
europepmc   +1 more source